As of 2026-09-17, the Relative Valuation of Emergent BioSolutions Inc (EBS) is 5.27 USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.75 USD, the upside of Emergent BioSolutions Inc based on Relative Valuation is -21.9%.
The range of the Relative Valuation is (2.06) - 16.65 USD.
| Range | Selected | |
| Trailing P/E multiples | 12.3x - 22.1x | 16.1x |
| Forward P/E multiples | 14.7x - 20.4x | 16.2x |
| Fair Price | (2.06) - 16.65 | 5.27 |
| Upside | -130.5% - 146.6% | -21.9% |
| Date | P/E |
| 2026-09-16 | -40.50 |
| 2026-09-15 | -38.16 |
| 2026-09-14 | -38.28 |
| 2026-09-11 | -37.38 |
| 2026-09-10 | -35.22 |
| 2026-09-09 | -34.08 |
| 2026-09-08 | -36.00 |
| 2026-09-04 | -37.26 |
| 2026-09-03 | -37.38 |
| 2026-09-02 | -38.76 |
| 2026-09-01 | -37.32 |
| 2026-08-31 | -36.60 |
| 2026-08-28 | -35.46 |
| 2026-08-27 | -35.64 |
| 2026-08-26 | -35.82 |
| 2026-08-25 | -33.84 |
| 2026-08-24 | -31.08 |
| 2026-08-21 | -30.48 |
| 2026-08-20 | -28.92 |
| 2026-08-19 | -29.34 |
| 2026-08-18 | -27.96 |
| 2026-08-17 | -27.00 |
| 2026-08-14 | -27.54 |
| 2026-08-13 | -26.94 |
| 2026-08-12 | -27.30 |
| 2026-08-11 | -26.70 |
| 2026-08-10 | -26.82 |
| 2026-08-07 | -29.04 |
| 2026-08-06 | -31.86 |
| 2026-08-05 | -45.24 |
| 2026-08-04 | -45.42 |
| 2026-08-03 | -44.46 |
| 2026-07-31 | -43.32 |
| 2026-07-30 | -43.56 |
| 2026-07-29 | -44.10 |
| 2026-07-28 | -43.86 |
| 2026-07-27 | -43.98 |
| 2026-07-24 | -43.56 |
| 2026-07-23 | -45.00 |
| 2026-07-22 | -45.48 |
| 2026-07-21 | -45.90 |
| 2026-07-20 | -46.14 |
| 2026-07-17 | -45.78 |
| 2026-07-16 | -46.14 |
| 2026-07-15 | -47.34 |
| 2026-07-14 | -45.00 |
| 2026-07-13 | -48.06 |
| 2026-07-10 | -48.30 |
| 2026-07-09 | -49.08 |
| 2026-07-08 | -48.84 |